Dahaba, Ashraf A. http://orcid.org/0000-0001-8513-3643
Xiao, Zhaoyang
Zhu, Xiaoling
Dong, Hailong
Xiong, Lize
Rehak, Peter
Zelzer, Sieglinde
Wang, Kun
Reibnegger, Gilbert
Clinical trials referenced in this document:
Documents that mention this clinical trial
Age progression from vicenarians (20–29 year) to nonagenarians (90–99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography
https://doi.org/10.1007/s10928-020-09678-0
Article History
Received: 26 November 2019
Accepted: 3 February 2020
First Online: 25 February 2020
Compliance with ethical standards
:
: All authors attest to the validity and legitimacy of the data and its interpretation, and agree to its submission. All authors have significantly contributed to the manuscript and no person or group of persons who actively contributed were excluded from the study. All authors confirm that they have read and approved the paper, have met the criteria for authorship as established by the International Committee of Medical Journals Editors, believe that the paper represents honest work, and are able to verify the validity of the results reported. All authors state that we have absolutely no conflicts of interest (including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest). None of the authors received honoraria from a company or were on the speaker’s bureau for any Organization, and there were no sources of financial support, corporate involvement or patent holdings other than the above mentioned grants from the Scientific Research Fund of Ministry of Health - Major Plan of Science and from above mentioned departmental sources. There was no support whatsoever from a pharmaceutical company or a manufacturer in editing of the protocol, financial support, drug supply, data analysis or writing of the paper.